ACM
VERA icon

ADAR1 Capital Management’s Vera Therapeutics VERA Stock Holding History

ADAR1 Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Buy
18,322
+2,289
+14% +$85.3K 0.04% 182
2026
Q1 		$645K Buy
16,033
+1,300
+9% +$56K 0.04% 189
2025
Q4 		$746K Buy
+14,733
New +$523K 0.05% 158
2024
Q3 		– Sell
-1,079
Closed -$39K – 343
2024
Q2 		$39K Buy
+1,079
New +$42.8K 0.01% 197

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ADAR1 Capital Management's VERA Position: Q2 2026 in Review

ADAR1 Capital Management increased its Vera Therapeutics (VERA) stake by 14% in Q2 2026, buying an estimated $85.3K and bringing the position to 18,322 shares worth $786K. The position accounts for 0.04% of the portfolio, ranked #182.

ADAR1 Capital Management first reported a position in VERA in Q2 2024 and has held it in 4 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • ADAR1 Capital Management held 18,322 shares of Vera Therapeutics worth $786K as of Q2 2026.
  • ADAR1 Capital Management bought 2,289 Vera Therapeutics shares in Q2 2026, an estimated $85.3K.
  • Vera Therapeutics made up 0.04% of ADAR1 Capital Management's portfolio in Q2 2026, its #182 holding.
  • ADAR1 Capital Management first reported a position in Vera Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.